COVID19 is on everyone’s mind now and you may wonder what you can do to help prevent you from getting the virus and/or to protect yourself from getting the more severe form of COVID19 that could kill you.
The news media has done a very good job of scarring everyone about the incidence of the virus, which is going up dramatically as more testing is performed. However, death rates appear to be leveling and are staying rather stable. In the DFW area, death rates are around 1.7% using only confirmed cases. If you add the estimated 35% who are asymptomatic, the death rate is around 1.2%, which is about the same death rate as the flu.
Who Dies of COVID19?
Around 90% to 95% of the people who die from COVID19 sequelae have comorbidities. In other words, they have one or more of the following: 
What Can You Do to Decrease You’re Risk of Dying from COVID19?
Most of us fear the sequelae of death from COVID19. It’s therefore obvious what we must do to prevent this sequela. According to HHS, most likely almost everyone will get COVID19 over time since it is such an infectious disease. Thus, if you want to decrease your chances of death from COVID, do the following:
Supplements to Boost Your Immune System
Other actions you can take include boosting your immune system efficiency so it can fight infectious agents better. Supplements may help, including curcumin, green tea extract, omega 3 fish oils, Vitamin D, Vitamin C and others with similar immune boosting supplements are beneficial.
Taking these types of supplements is a great way to potentially protect yourself from many age-related chronic medical illnesses, including heart disease, cancers, Alzheimer’s disease and other dementias. Maximize the immune boosting benefits of these supplements to improve your health. Combined with losing weight, exercising and staying fit and healthy, they may also help you to fight off COVID19 and other viral infections too.
One especially important supplement to take is Vitamin D. As you can see from the graph below, darker skin colored races seem to have worse outcomes from COVID19 than lighter colored ones. In addition, because the darker skin blocks sun’s UV rays from penetrating the skin to produce Vitamin D within you body, most darker colored skin people tend to have very low Vitamin D levels.
It has been proven that those people with low Vitamin D levels tend to have more severe cases of COVID. If you have low vitamin D levels, there is a 70% protective effect when Vitamin D deficiency is corrected with supplementation. This is partly the reason for the disparity noted on the graph below. Of course, there are other reasons, as noted on the CDC site. But boosting your level of Vitamin D is a good way to potentially reduce your risk no matter what race you are.
Peptides for COVID19
Peptides are compounds that signal certain processes to occur within your body. One potentially beneficial peptide for COVID19 is called Thymosin. This peptide helps activate T-cells to be more efficient in killing invading microorganisms such as bacteria and viruses.
T-cells are immune cells produced by in your bone marrow along with the other blood products such as your red and other white blood cells. Another name for them are Killer T-cells. They essentially kill viruses and bacteria that have infected your cells. The T-cells basically drill a hole into the infected cell and secret cytotoxins into the cell. These cytotoxins kill the viruses and bacteria within the cell. When enough of these eradicate the virus or bacteria from your body, you’re cured.
When you’re a child, you have a thymus gland in your chest which makes T-cells. It also secretes a substance which activates the T-cells that were made within the bone marrow. This substance is thymosin, a peptide produced by the thymus gland.
Unfortunately, as you get older, your thymus gland gets smaller and smaller until it is almost hardly perceptible in your 70’s, having been replaced with just fat. Along with this decline in the thymus is a corresponding decline in immune efficiency. This immune decline makes older people more susceptible to diseases such as viral and bacterial diseases.
COVID19 produces hardly any attacks on children. In fact, most children are either asymptomatic yet have the virus, or they have minimal symptoms. The older you get the more likely that COVID19 will result in severe sequelae and even death. This is exemplified in the above graph from the CDC:
The older you get, the higher chance you could die from COVID19. However, there is something you can do to potentially reduce this risk. That something is to inject thymosin into your body to activate your T-cells in a similar fashion as what your thymus did when you were young. Thymosin has been shown to decrease the severity of COVID19. Thymosin injections are available and are easily administered.
Although controversial, hydroxychloroquine therapy can decrease the severity of COVID19 infections as discussed in a prior blog. A recent study performed at the Henry Ford Hospital in Michigan demonstrated a 39% decrease in fatal outcomes from COVID19 when HCQ was used.
How TrueMD Can Help You
We have many options available for you at TrueMD that you could do to help you in preventing the severe sequelae from COVID19. Here’s a summary:
If you are interested in getting started on any of these actions, call our office for a consultation and let’s see how we can help you get your body in better shape to not only fight off COVID19, but also to live life better with better health. There’s no reason to let your guard down to the Corona virus when there are actions you can do.
 Baun S. How Comorbidities Affect COVID-19 Severity in the U.S. NEJM Journal Watch. April 3, 2020. https://www.jwatch.org/na51296/2020/04/03/how-comorbidities-affect-covid-19-severity-us
 Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020;55(5):2000547. Published 2020 May 14. doi:10.1183/13993003.00547-2020
 Petrakis D, et al. Obesity ‑ a risk factor for increased COVID‑19 prevalence, severity and lethality (Review). Molecular Medicine Reports. 22(1) July 2020. https://doi.org/10.3892/mmr.2020.11127
 Rubano, S. New Study Reveals Diabetes is Among the Top Three COVID-19 Comorbidities. Diabetes in Control. Jun 2, 2020. http://www.diabetesincontrol.com/new-study-reveals-diabetes-is-among-the-top-three-covid-19-comorbidities/
 H Mian, SJ Grant, M Engelhardt, et al. Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. Journal of geriatric Oncology. 11(2020)764-768. https://www.geriatriconcology.net/article/S1879-4068(20)30190-9/pdf
 Zahedipour F, et al. Potential effects of curcumin in the treatment of COVID ‐19 infection. Phytotherapy Research/Early View. 19 May 2020. https://doi.org/10.1002/ptr.6738
 El Barky AR. How to Avoid Coronavirus (COVID-19) or Relief it is Symptoms by Natural Products. Annals of Epidemiology & Public Health. Jun 2020, Link
 Kakodkar P, Kaka N, Baig MN. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus. 2020;12(4):e7560. Published 2020 Apr 6. doi:10.7759/cureus.7560
 Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. Published 2017 Feb 15. doi:10.1136/bmj.i6583
 Alipio, Mark, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus-2019 (COVID-19) (April 9, 2020). Available at SSRN: https://ssrn.com/abstract=3571484 or http://dx.doi.org/10.2139/ssrn.3571484
 Ludvigsson JF. Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica. 109(6). 23 March 2020. https://doi.org/10.1111/apa.15270
 Yueping Liu, Yue Pang, Zhenhong Hu, Ming Wu, Chenhui Wang, Zeqing Feng, Congzheng Mao, Yingjun Tan, Ying Liu, Li Chen, Min Li, Gang Wang, Zilin Yuan, Bo Diao, Yuzhang Wu, Yongwen Chen, Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells, Clinical Infectious Diseases, , ciaa630, https://doi.org/10.1093/cid/ciaa630
 Lee TC, et al. An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can’t Get No) Satisfaction. Intern. J. of Infectious dis. July 02, 2020DOI:https://doi.org/10.1016/j.ijid.2020.06.095. https://www.ijidonline.com/article/S1201-9712(20)30530-0/fulltext
 Sardu, C.; Gambardella, J.; Morelli, M.B.; Wang, X.; Marfella, R.; Santulli, G. Is COVID-19 an Endothelial Disease? Clinical and Basic Evidence. Preprints 2020, 2020040204 (doi: 10.20944/preprints202004.0204.v1).